Two research results of BRL Medcine will be presented at the 65th American Society of Hematology Annual Meeting
The world’s first patient to receive BRL-201 non-viral PD1-CAR-T treatment has been cancer-free for more than 3 years!
Another milestone! BRL Medicine's new generation of universal CAR-T therapy has been approved by domestic IND
Nature Biotechnology published ! BRL medicine team developed an accurate and efficient adenine transversion editors
BRL Medicine’s BRL-201 research results published in the sub-journal of The Lancet
The research results of BRL-101 will be presented at the 26th ASGCT and the 28th EHA Annual Meeting